Fortis Healthcare Q1 Profit Up 2.3% on Strong Hospital Growth

Fortis Healthcare recorded a 2.3% year-on-year increase in consolidated net profit, reaching ₹266.4 crore for the first quarter of FY27. This growth accompanied a 17.5% rise in revenue from operations, totaling ₹2,545 crore.

Q1 FY27 Key Financials

• Consolidated Net Profit: ₹266.4 crore (up 2.3% YoY from ₹260.3 crore)
• Revenue from Operations: ₹2,545 crore (up 17.5% YoY from ₹2,166.7 crore)
• EBITDA: ₹537.1 crore (up 9.5%)
• EBITDA Margin: 21.1% (down from 22.6% in prior year)

The hospital business proved a significant growth engine, with revenue climbing 19% year-on-year to ₹2,187 crore in Q1 FY27. This performance stemmed from a 16.7% increase in occupied beds and a moderate rise in average revenue per occupied bed.

Hospital Segment Performance

• Hospital Revenue: ₹2,187 crore (up 19% YoY)
• Occupied Beds: Increased by 16.7%
• Like-for-like Operating EBITDA Margins: Consistent at 22% (excluding new facilities)
• Growth Drivers: Recent acquisitions in Punjab and Bengaluru, leased facility in Delhi-NCR

Fortis Healthcare is strategically expanding its geographical reach, entering Odisha through an operations and management agreement for a new 300-bed greenfield multi-specialty hospital in Cuttack. The company also plans brownfield expansions, aiming to add approximately 1,800 beds over the next four to five years.

Strategic Expansion & Outlook

• Odisha Entry: 300-bed multi-specialty hospital in Cuttack via O&M agreement
• Brownfield Expansion: Add approximately 1,800 beds over next 4-5 years
• Focus Areas: Dense catchment areas in key clusters like Delhi-NCR

The diagnostics division, Agilus, further bolstered performance by extending its network to 4,493 customer touch points. Agilus processed around 10.46 million tests in Q1 FY27, demonstrating robust growth across its portfolios.

• Agilus Customer Touch Points: 4,493
• Tests Conducted (Q1 FY27): Approximately 10.46 million
• Preventive Portfolio Revenue Growth: 27%
• Specialized Portfolio Revenue Growth: 13%

As of June 30, 2026, Fortis Healthcare’s net debt stood at ₹2,233 crore, alongside a net debt to EBITDA ratio of 1.01 times and a net debt to equity ratio of 0.21 times. Dr. Ashutosh Raghuvanshi, MD and CEO, noted the positive start to the financial year, emphasizing the company’s dedication to clinical excellence, technology-led care, strategic expansions, and an operational focus.

Fortis anticipates revenue growth aligned with market trends, projecting a gradual improvement in operating EBITDA margins to the mid-twenties. This outlook underpins the company’s expansion and operational efficiency initiatives.